Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10019447HBVENSG00000159403.18protein_codingC1RNoNo715P00736
TVIS10061391HBVENSG00000159403.18protein_codingC1RNoNo715P00736
TVIS10061390HBVENSG00000159403.18protein_codingC1RNoNo715P00736
TVIS10061392HBVENSG00000159403.18protein_codingC1RNoNo715P00736
TVIS10061387HBVENSG00000159403.18protein_codingC1RNoNo715P00736
TVIS10061393HBVENSG00000159403.18protein_codingC1RNoNo715P00736
TVIS10061388HBVENSG00000159403.18protein_codingC1RNoNo715P00736
TVIS10061389HBVENSG00000159403.18protein_codingC1RNoNo715P00736
TCGA Plot Options
Drug Information
GeneC1R
DrugBank IDDB01593
Drug NameZinc
Target IDBE0002093
UniProt IDP00736
Regulation Type
PubMed IDs23896426
CitationsWang F, Chmil C, Pierce F, Ganapathy K, Gump BB, MacKenzie JA, Metchref Y, Bendinskas K: Immobilized metal affinity chromatography and human serum proteomics. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Sep 1;934:26-33. doi: 10.1016/j.jchromb.2013.06.032. Epub 2013 Jul 5.
GroupsApproved; Investigational
Direct ClassificationHomogeneous transition metal compounds
SMILES[Zn]
PathwaysDihydropyrimidinase Deficiency; Rofecoxib Action Pathway; Losartan Action Pathway; AICA-Ribosiduria; Canavan Disease; Quinapril Action Pathway; Alkaptonuria; Eprosartan Action Pathway; gamma-Glutamyltransferase Deficiency; Pterine Biosynthesis; Sulindac Action Pathway; Rescinnamine Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); beta-Ureidopropionase Deficiency; Vitamin B6 Metabolism; Retinol Metabolism; Valsartan Action Pathway; Valdecoxib Action Pathway; Irbesartan Action Pathway; Adenosine Deaminase Deficiency; Hawkinsinuria; Methionine Metabolism; Ramipril Action Pathway; Benazepril Action Pathway; beta-Alanine Metabolism; Aspartate Metabolism; Diclofenac Action Pathway; Galactosemia
PharmGKBPA451956
ChEMBLCHEMBL1201279